FINISHED DOSAGE FORMULATIONS
SHELLAC
Route : ORAL
CAS :
UNII : 46N107B71O
Potency Amount : 31.2
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SHELLAC
Route : ORAL
CAS :
UNII : 46N107B71O
Potency Amount : 34.48
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SHELLAC
Route : ORAL
CAS :
UNII : 46N107B71O
Potency Amount : 0.43
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SHELLAC
Route : ORAL
CAS :
UNII : 46N107B71O
Potency Amount : 0
Potency Unit : NA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SHELLAC
Route : ORAL
CAS :
UNII : 46N107B71O
Potency Amount : 75.01
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SHELLAC
Route : ORAL
CAS :
UNII : 46N107B71O
Potency Amount : 18
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SHELLAC
Route : ORAL
CAS :
UNII : 46N107B71O
Potency Amount : 3.4
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SHELLAC
Route : ORAL
CAS :
UNII : 46N107B71O
Potency Amount : 21.44
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SHELLAC
Route : ORAL
CAS :
UNII : 46N107B71O
Potency Amount : 0.74
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SHELLAC
Route : ORAL
CAS :
UNII : 46N107B71O
Potency Amount : 213.24
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
REF. STANDARDS & IMPURITIES
LOOKING FOR A SUPPLIER?